We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| PAO Group Inc (PK) | USOTC:PAOG | OTCMarkets | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.0009 | 0.0009 | 0.0009 | 0.00 | 01:00:00 |
Dallas, TX -- November 13, 2020 -- InvestorsHub NewsWire -- Puration, Inc. (OTC Pink: PURA) today announced an interview of CEO, Brian Shibley conducted by CEO Roadshow in association with OTC PR Wire (www.otcprwire.com) - the #1 solution for press, financial disclosure and multimedia solutions for companies trading in the OTC Market, will be released on Monday, November 16, 2020. The interview will focus on PURA's recent acquisition of a 72-acre property in Farmersville, Texas as the foundation of an innovative, hemp processing plant. PURA is building partnerships to participate in the project to include a pharmaceutical and neurocritical extraction partnership with PAO Group, Inc. (OTC Pink: PAOG) and a co-packing partnership with Alkame Holdings, Inc. (OTC Pink: ALKM). Earlier this week, PURA published a multimedia presentation on the new initiative in Texas:
PURA Targets Hemp Consumer Advocates To Capture $26 Billion Market
Sign up to receive the latest updates at www.purationinc.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
1 Year PAO (PK) Chart |
1 Month PAO (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
